Views
1 year ago

Mupirocina, Antibióticos que actúan sobre la síntesis proteica. L. Roperti Deguisa, J. C. Fernández, H. A. Serra

  • Text
  • Juan fernandez
  • Alejandro serra
  • Roperti deguisa
  • Antibióticos
  • Síntesis proteica
  • Mupirocina
  • Wwwscienscomar
  • Espectinomicina
  • Coli
  • Serra
  • Resistance
  • Rrna
  • Resistencia
  • Chemother
  • Ribosomal
  • Estreptograminas
  • Antimicrob
Mupirocina, Antibióticos que actúan sobre la síntesis proteica. L. Roperti Deguisa, J. C. Fernández, H. A. Serra

HA

HA Serra // Antibióticos Referencias bibliográficas 1. Agmon I, Auerbach T, Baram D, et al. On peptide bond formation, translocation, nascent protein progression and the regulatory properties of ribosomes. Eur J Biochem 2003; 270: 2543-56. 2. Ban N, Nissen P, Hansen J, et al. Placement of protein and RNA structures into a 5 Å-resolution map of the 50S ribosomal subunit. Nature 1999; 400: 841-7. Barriere JC, Berthaud N, Beyer D et al. Recent developments in streptogramin research. Curr Pharm Des 1998; 4: 155-80. 3. Bocchetta M, Xiong L, Mankin AS. 23S rRNA positions essential for tRNA binding in ribosomal functional sites. Proc Natl Acad Sci USA 1998; 95: 3525-30. 4. Bohn C, Bouloc P. The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-D-thiogalacto-pyranoside exclusion and spectinomycin sensitivity. J Bacteriol 1998; 180: 6072-75. 5. Bories GF, Cravedi JP. Metabolism of chloramphenicol: A story of nearly 50 years. Drug Metab Rev 1994; 26: 767-83. 6. Carter AP, Clemons Jr. WM, Brodersen DE, et al. Functional insights from the structure of 30S ribosomal subunit and its interactions with antibiotics. Nature 2000; 407: 340-8. 7. Champney WS, Tober CL. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. Antimicrob Agents Chemother 1999; 43: 1324-8. 8. Christiansen K. Fusidic acid adverse drug reactions. Int J Antimicrob Agents 1999; 12 Suppl 2: S3-S9. 9. Clark NC, Olsvik Ø, Swenson JM, et al. Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis. Antimicrob Agents Chemother 1999; 43: 157-60. 10. Douthwaite S, Champney WS. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. J Antimicrob Chemother 2001; 48 Suppl T1: 1-8. 11. Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother 2011; 66 suppl 4: iv7-15. 12. Feldman WE, Sweighaft T. Effect of ampicillin and chloramphenicol against Streptococcus pneumoniae and Neisseria meningitidis. Antimicrobial Agents and Chemotherapy 1979; 15: 240-2. 13. Fitzhugh AL. Antibiotic inhibitors of the peptidyl transferase center. 1. Clindamycin as a composite analogue of the transfer RNA fragments L-Pro-Met and the D-ribosyl ring of adenosine. Bioorg Med Chem Lett 1998; 8: 87-92. 14. Fourmy D, Recht MI, Blanchard SC, Puglisi JD. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science. 1996; 274: 1367-71. 15. Gisby J, Bryant J. Efficacy of a new cream formulation of mupirocin: Comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 2000; 44: 255-60. 16. Greer ND. Tigecycline (Tygacil): The first in glycylcycline class of antibiotics. Proc (Bayl Univ Med Cent) 2006; 19: 155-61. 17. Griffey RH, Hofstadler SA, Sannes-Lowery KA, et al. Determinants of aminoglycoside-binding spe-

cificity for rRNA by using mass spectrometry. Proc Natl Acad Sci USA 1999; 96: 10129-33. 18. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: Management considerations. Br J Clin Pharmacol 2011; 72: 381-93. 19. Henrich B, Hopfe M, Kitzerow A, et al. The adherence-associated lipoprotein P100, encoded by an app operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis. J Bacteriol 1999; 181: 4873-8. 20. Holt DE, Andrews CM, Payne JP et al. The myelotoxicity of chloramphenicol: In vivo and in vitro studies: II: In vivo myelotoxicity in the B6C3F mouse. Hum Exp Toxicol 1998; 17: 8-17. 21. Ishino T, Atarashi K, Uchiyama S et al. Interaction of ribosome recycling factor and elongation factor EF-G with E coli ribosomes studied by the surface plasmon resonance technique. Genes Cells 2000; 5: 953-63. 22. Laporte JR, Vidal X, Ballarin E, Ibanez L. Possible association between ocular chloramphenicol and aplastic anaemia-the absolute risk is very low. Br J Clin Pharmacol 1998; 46: 181-4. 23. Laurberg M, Kristensen O, Martemyanov K, et al. A. Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol 2000; 303: 593-603. 24. Levy SB, McMurry LM, Barbosa TM, et al. Nomenclature for new tetracycline resistance determinants. Antimicrob Agents Chemother 1999; 43:1523-4. 25. Li W, Atkinson GC, Thakor NS, et al. Mechanism of tetracycline resistance by ribosomal protection protein Tet(O). Nat Commun 2013; 4: 1477. doi: 10.1038/ncomms.2470. 26. Lovmar M, Tenson T, Ehrenberg M. Kinetics of macrolide action. The josamicin and erythromycin cases. J Biol Chem 2004; 279: 53506-15. 27. Martemyanov KA, Gudkov AT. Domain III of elongation factor G from Thermus thermophilus is essential for induction of GTP hydrolysis on the ribosome. J Biol Chem 2000; 275: 35820-4. 28. Menninger JR. Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics. J Basic Clin Physiol Pharmacol 1995; 6: 229-50. 29. Milberg P, Eckardt L, Bruns HJ, et al. Divergent proarrhytmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarization and torsade de pointes. J Pharmacol Exp Ther 2002; 303: 218-25. 30. Mingeot-Leclerq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: Activity and resistance. Antimicrob Agents Chemother 1999; 43: 727-37. 31. Nakamatsu EH, Fujihira E, Ferreira RC, et al. Oligopeptide uptake and aminoglycoside resistance in Escherichia coli K12. FEMS Microbiol Lett 2007; 269: 229-33. 32. Nissen P, Thirup S, Kjeldgaard M, Nyborg J. The crystal structure of Cys-tRNA Cys -EF-Tu-GDPNP reveals general and specific features in the ternary complex and in tRNA. Structure 1999; 7: 143-56. 33. Ogle JM, Brodersen DE, Clemons Jr. WM, et al. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 2001; 292: 897-902. 34. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in anaerobes. Clin Infect Dis 1997; 24 Suppl 1: S110-S120. 35. Roberts MC, Sutcliffe J, Courvalin P. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-30. 181

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015